406 related articles for article (PubMed ID: 19057660)
1. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
Wheeler RT; Kombe D; Agarwala SD; Fink GR
PLoS Pathog; 2008 Dec; 4(12):e1000227. PubMed ID: 19057660
[TBL] [Abstract][Full Text] [Related]
2. Caspofungin-induced β(1,3)-glucan exposure in
Wagner AS; Lumsdaine SW; Mangrum MM; Reynolds TB
mBio; 2023 Aug; 14(4):e0007423. PubMed ID: 37377417
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.
Rueda C; Cuenca-Estrella M; Zaragoza O
Antimicrob Agents Chemother; 2014; 58(2):1071-83. PubMed ID: 24295973
[TBL] [Abstract][Full Text] [Related]
4. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.
Lamaris GA; Lewis RE; Chamilos G; May GS; Safdar A; Walsh TJ; Raad II; Kontoyiannis DP
J Infect Dis; 2008 Jul; 198(2):186-92. PubMed ID: 18500936
[TBL] [Abstract][Full Text] [Related]
5. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1.
Marakalala MJ; Vautier S; Potrykus J; Walker LA; Shepardson KM; Hopke A; Mora-Montes HM; Kerrigan A; Netea MG; Murray GI; Maccallum DM; Wheeler R; Munro CA; Gow NA; Cramer RA; Brown AJ; Brown GD
PLoS Pathog; 2013; 9(4):e1003315. PubMed ID: 23637604
[TBL] [Abstract][Full Text] [Related]
6. A drug-sensitive genetic network masks fungi from the immune system.
Wheeler RT; Fink GR
PLoS Pathog; 2006 Apr; 2(4):e35. PubMed ID: 16652171
[TBL] [Abstract][Full Text] [Related]
7. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure.
Hohl TM; Feldmesser M; Perlin DS; Pamer EG
J Infect Dis; 2008 Jul; 198(2):176-85. PubMed ID: 18500928
[TBL] [Abstract][Full Text] [Related]
8. Interactions of liposome carriers with infectious fungal hyphae reveals the role of β-glucans.
Chavan NL; Young JK; Drezek RA; Lewis R; Bikram M
Mol Pharm; 2012 Sep; 9(9):2489-96. PubMed ID: 22770505
[TBL] [Abstract][Full Text] [Related]
9. Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans.
Wiederhold NP; Najvar LK; Bocanegra RA; Kirkpatrick WR; Patterson TF
Antimicrob Agents Chemother; 2011 Jul; 55(7):3254-60. PubMed ID: 21502632
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
Zhang J; Silao FG; Bigol UG; Bungay AA; Nicolas MG; Heitman J; Chen YL
PLoS One; 2012; 7(8):e44192. PubMed ID: 22952924
[TBL] [Abstract][Full Text] [Related]
11. β-(1,3)-Glucan Unmasking in Some Candida albicans Mutants Correlates with Increases in Cell Wall Surface Roughness and Decreases in Cell Wall Elasticity.
Hasim S; Allison DP; Retterer ST; Hopke A; Wheeler RT; Doktycz MJ; Reynolds TB
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27849179
[TBL] [Abstract][Full Text] [Related]
12. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
Stevens DA; Ichinomiya M; Koshi Y; Horiuchi H
Antimicrob Agents Chemother; 2006 Sep; 50(9):3160-1. PubMed ID: 16940118
[TBL] [Abstract][Full Text] [Related]
13. Nature of β-1,3-Glucan-Exposing Features on Candida albicans Cell Wall and Their Modulation.
de Assis LJ; Bain JM; Liddle C; Leaves I; Hacker C; Peres da Silva R; Yuecel R; Bebes A; Stead D; Childers DS; Pradhan A; Mackenzie K; Lagree K; Larcombe DE; Ma Q; Avelar GM; Netea MG; Erwig LP; Mitchell AP; Brown GD; Gow NAR; Brown AJP
mBio; 2022 Dec; 13(6):e0260522. PubMed ID: 36218369
[TBL] [Abstract][Full Text] [Related]
14. Pga26 mediates filamentation and biofilm formation and is required for virulence in Candida albicans.
Laforet L; Moreno I; Sánchez-Fresneda R; Martínez-Esparza M; Martínez JP; Argüelles JC; de Groot PW; Valentín-Gomez E
FEMS Yeast Res; 2011 Aug; 11(5):389-97. PubMed ID: 21439008
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Vediyappan G; Rossignol T; d'Enfert C
Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
[TBL] [Abstract][Full Text] [Related]
16. Induction of a high affinity fibronectin receptor in Candida albicans by caspofungin: requirements for beta (1,6) glucans and the developmental regulator Hbr1p.
Pendrak ML; Rodrigues RG; Roberts DD
Med Mycol; 2007 Mar; 45(2):157-68. PubMed ID: 17365652
[TBL] [Abstract][Full Text] [Related]
17. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.
Lee KK; Maccallum DM; Jacobsen MD; Walker LA; Odds FC; Gow NA; Munro CA
Antimicrob Agents Chemother; 2012 Jan; 56(1):208-17. PubMed ID: 21986821
[TBL] [Abstract][Full Text] [Related]
18. Identification of 10 genes on
Sah SK; Yadav A; Kruppa MD; Rustchenko E
Microbiol Spectr; 2023 Dec; 11(6):e0329523. PubMed ID: 37966256
[No Abstract] [Full Text] [Related]
19. Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents.
Hoehamer CF; Cummings ED; Hilliard GM; Rogers PD
Antimicrob Agents Chemother; 2010 May; 54(5):1655-64. PubMed ID: 20145080
[TBL] [Abstract][Full Text] [Related]
20. Cek1 regulates ß(1,3)-glucan exposure through calcineurin effectors in Candida albicans.
Wagner AS; Lumsdaine SW; Mangrum MM; King AE; Hancock TJ; Sparer TE; Reynolds TB
PLoS Genet; 2022 Sep; 18(9):e1010405. PubMed ID: 36121853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
